SALT LAKE CITY, Oct. 28, 2021 /PRNewswire/ -- PolarityTE, Inc.
(Nasdaq: PTE) today announced that it will report results for
the quarter ended September 30, 2021
by press release on Wednesday, November 10,
2021 at approximately 7:00 a.m.
Eastern Time.
In addition, the Company will host a conference call and webcast
with Q&A on November 10, 2021 at
8:30 a.m. Eastern Time. The
conference call can be accessed by calling 1-800-581-5838 (U.S. and
Canada) or +44 (0)330 336 9104
(International) with confirmation code 612545 and referencing
"PolarityTE Third Quarter 2021 Earnings Call". A webcast of
the conference call can be accessed by using the link below.
Earnings Call Webcast – CLICK HERE
A replay of the earnings conference call will be available for
30 days, beginning approximately one hour after the conclusion of
the call and can be found by visiting PolarityTE's website at
https://www.polarityte.com/news-media/events, or by clicking on the
link above.
About PolarityTE®
PolarityTE is focused on
transforming the lives of patients by discovering, designing, and
developing a range of regenerative tissue products and biomaterials
for the fields of medicine, biomedical engineering and material
sciences. Rather than manufacturing with synthetic and foreign
materials within artificially engineered environments, PolarityTE
manufactures products from the patient's own tissue and uses the
patient's own body to support the regenerative process. From a
small piece of healthy autologous tissue, the company creates an
easily deployable, dynamic, and self-propagating product designed
to regenerate the target tissues. PolarityTE's innovative methods
are intended to promote and accelerate growth of the patient's
tissues to undergo a form of effective regenerative healing.
PolarityTE's products, including SkinTE, are in the development
stage, and are not approved or available for clinical use. Learn
more at www.PolarityTE.com – Welcome to the Shift®.
Forward Looking Statements
Certain statements
contained in this release are "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995. They are generally identified by words such as "believes,"
"may," "expects," "anticipates," "intend," "plan," "will," "would,"
"should" and similar expressions. Readers should not place undue
reliance on such forward-looking statements, which are based upon
the Company's beliefs and assumptions as of the date of this
release. The Company's actual results could differ materially due
to the impact of the COVID-19 pandemic, future clinical studies,
and FDA regulatory matters, which cannot be predicted, and the risk
factors and other items described in more detail in the "Risk
Factors" section of the Company's Annual Reports and other filings
with the SEC (copies of which may be obtained at www.sec.gov).
Subsequent events and developments may cause these forward-looking
statements to change. The Company specifically disclaims any
obligation or intention to update or revise these forward-looking
statements as a result of changed events or circumstances that
occur after the date of this release, except as required by
applicable law.
POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES
SELF and WELCOME TO THE SHIFT are registered trademarks of
PolarityTE, Inc.
CONTACT
Investors:
PolarityTE Investor Relations
ir@PolarityTE.com
385-831-5284
View original content to download
multimedia:https://www.prnewswire.com/news-releases/polarityte-to-report-third-quarter-financial-results-on-november-10-2021-301410546.html
SOURCE PolarityTE, Inc.